Component-Resolved Diagnosis of American Cockroach ( Periplaneta americana ) Allergy in Patients From Different Geographical Areas
Manifestation of respiratory allergy to American cockroach ( ) is prominent in the subtropical and tropical areas. However, co-existing perennial indoor inhalant allergies frequently compromise clinical diagnosis of cockroach allergy, and the analysis of sensitization pattern is limited by the lack...
Gespeichert in:
Veröffentlicht in: | Frontiers in allergy 2021-06, Vol.2, p.691627-691627 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Manifestation of respiratory allergy to American cockroach (
) is prominent in the subtropical and tropical areas. However, co-existing perennial indoor inhalant allergies frequently compromise clinical diagnosis of cockroach allergy, and the analysis of sensitization pattern is limited by the lack of
allergens widely available for component-resolved diagnostics (CRD).
To evaluate a collection of previously described recombinant
allergens for CRD in cockroach allergy.
A panel of nine recombinant
a allergens (Per a 1-5, 7-10) was generated, purified, and subjected to physicochemical characterization by applying circular dichroism (CD) spectroscopy, dynamic light scattering (DLS), amino acid (AA) analysis, and mass spectrometry (MS). Patients (
= 117) from India, Korea, Venezuela, and Iran, reporting perennial respiratory indoor allergies with IgE sensitization to cockroach (
), were included. The sensitization profile was monitored by the experimental ImmunoCAP testing.
ImmunoCAP testing confirmed IgE sensitization to
and/or
extract in 98 of 117 patients (
= 0.95). Five out of 117 patients were sensitized to only one of the two cockroach species. Within the whole study group, the prevalence of sensitization to individual allergens varied from 4% (Per a 2) to 50% (Per a 9), with the highest IgE values to Per a 9. Patients from four countries displayed different sensitization profiles at which Per a 3 and Per a 9 were identified as major allergens in India and Korea.
-derived lipocalin and myosin light chain were characterized as new minor allergens, designated as Per a 4 and Per a 8.
extract showed higher diagnostic sensitivity than all individual components combined, suggesting the existence of allergens yet to be discovered.
Utilization of a panel of purified
allergens revealed highly heterogeneous sensitization patterns and allowed the classification of lipocalin and myosin light chain from
as new minor allergens. |
---|---|
ISSN: | 2673-6101 2673-6101 |
DOI: | 10.3389/falgy.2021.691627 |